Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1. | Cells | 2024 | 39682688 | PubTator, text mining | PubMed |
| Metabolomics-driven approaches for identifying therapeutic targets in drug discovery. | MedComm (2020) | 2024 | 39534557 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Unraveling modulation effects on albumin synthesis and inflammation by Striatin, a bioactive protein fraction isolated from Channa striata: In silico proteomics and in vitro approaches. | Heliyon | 2024 | 39398063 | PubTator, text mining | PubMed |
| Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs. | ACS Chem Biol | 2024 | 39264973 | PubTator, text mining | PubMed |
| Different estimation techniques and data analysis for constant-partially accelerated life tests for power half-logistic distribution. | Sci Rep | 2024 | 39242750 | PubTator, text mining | PubMed |
| The Disorderly Nature of Caliciviruses. | Viruses | 2024 | 39205298 | PubTator, text mining | PubMed |
| Expanding the horizons of targeted protein degradation: A non-small molecule perspective. | Acta Pharm Sin B | 2024 | 38828146 | PubTator, text mining | PubMed |
| Brought to Light: A Fluorogenic Probe to Monitor Immunosuppressants. | ACS Cent Sci | 2024 | 38799673 | PubTator, text mining | PubMed |
| Nonperturbative Fluorogenic Labeling of Immunophilins Enables the Wash-free Detection of Immunosuppressants. | ACS Cent Sci | 2024 | 38799658 | PubTator, text mining | PubMed |
| The Role of FKBPs in Complex Disorders: Neuropsychiatric Diseases, Cancer, and Type 2 Diabetes Mellitus. | Cells | 2024 | 38786025 | PubTator, text mining | PubMed |
| Bacterial Chaperone Domain Insertions Convert Human FKBP12 into an Excellent Protein-Folding Catalyst-A Structural and Functional Analysis. | Molecules | 2024 | 38611720 | PubTator, text mining | PubMed |
| Use of DNA forceps to measure receptor-ligand dissociation equilibrium constants in a single-molecule competition assay. | Methods Enzymol | 2024 | 38492958 | PubTator, text mining | PubMed |
| 'Getting Better'-Is It a Feasible Strategy of Broad Pan-Antiherpesviral Drug Targeting by Using the Nuclear Egress-Directed Mechanism? | Int J Mol Sci | 2024 | 38474070 | PubTator, text mining | PubMed |
| Evaluation of Tacrolimus' Adverse Effects on Zebrafish in Larval and Adult Stages by Using Multiple Physiological and Behavioral Endpoints. | Biology (Basel) | 2024 | 38392330 | PubTator, text mining | PubMed |
| Novel BRET combination for detection of rapamycin-induced protein dimerization using luciferase from fungus Neonothopanusnambi. | Heliyon | 2024 | 38384550 | PubTator, text mining | PubMed |
| DENND6A links Arl8b to a Rab34/RILP/dynein complex, regulating lysosomal positioning and autophagy. | Nat Commun | 2024 | 38296963 | PubTator, text mining | PubMed |
| A Tandem-Affinity Purification Method for Identification of Primary Intracellular Drug-Binding Proteins. | ACS Chem Biol | 2024 | 38271588 | PubTator, text mining | PubMed |
| From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation. | Pharmaceuticals (Basel) | 2024 | 38256933 | PubTator, text mining | PubMed |
| Antidiabetic Drugs in Breast Cancer Patients. | Cancers (Basel) | 2024 | 38254789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=4